SCHEMBL4742771

SCHEMBL4742771

NC(=O)OS(=O)(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27555295 0.94 CA2 (0.35)
Octane SCHEMBL28167855 0.81 CA2 (0.44)
SCHEMBL1193790 0.76 ALDH1A1 (0.33)
SCHEMBL27872309 0.75 BLM (0.32)
SCHEMBL1947040 0.73
SCHEMBL3067997 0.72 CA2 (0.44)
SCHEMBL4363246 0.72 CA2 (0.44)
SCHEMBL9666595 0.71 CA2 (0.32)
SCHEMBL23152425 0.71
SCHEMBL2305166 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111234823-A Synthesis method of quantum dots 宁波东旭成新材料科技有限公司 2020-06-05 CN claimed
CN-1788037-A Radiation curable compositions DSM IP ASSETS BV (NL) 2006-06-14 CN claimed
CN-119101552-A Environment-friendly composite lithium-based lubricating grease composition with high temperature and high extreme pressure and preparation method thereof 亚培烯科技(上海)有限公司 2024-12-10 CN disclosed
CN-117897477-A Immortalized cell lines for engineered synthetic leather 维特罗实验室公司 2024-04-16 CN disclosed
WO-2024044229-A2 SCAFFOLD MATERIALS FOR ARTIFICIAL DERMAL LAYER VITROLABS INC (US) 2024-02-29 WO disclosed
US-20240043805-A1 IMMORTALIZED CELL LINE FOR ENGINEERED SYNTHETIC LEATHER VITROLABS INC 2024-02-08 US disclosed
EP-4294910-A1 IMMORTALIZED CELL LINE FOR ENGINEERED SYNTHETIC LEATHER VitroLabs Inc (US) 2023-12-27 EP disclosed
CN-116390917-A MRGX2 antagonists 葛兰素史密斯克莱知识产权发展有限公司 2023-07-04 CN disclosed
CN-115038451-A Multimodal compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-09 CN disclosed
CN-115003279-A Prodrug compositions and methods of treatment 阿奎斯蒂弗医疗股份有限公司 2022-09-02 CN disclosed
EP-3313460-B1 FABRICS AND METHODS OF MAKING THEM FROM CULTURED CELLS MODERN MEADOW INC (US) 2021-11-10 EP disclosed
EP-0555351-A1 OXYSULFONYL CARBAMATES. WARNER LAMBERT CO (US) 1993-08-18 EP disclosed
US-5134072-A Preparation of a water-soluble modified enzyme by covalently bonding an enzyme to a polyurethane pre-polymer/bisulfite adduct BOEHRINGER MANNHEIM GMBH (DE) 1992-07-28 US disclosed
WO-1992007826-A1 OXYSULFONYL CARBAMATES WARNER-LAMBERT COMPANY (US) 1992-05-14 WO disclosed
EP-0280212-B1 POLYURETHANE-MODIFIED ENZYME Roche Diagnostics GmbH (DE) 1991-05-29 EP disclosed
EP-0280212-A2 Polyurethane-modified enzyme Roche Diagnostics GmbH (DE) 1988-08-31 EP disclosed
EP-0168835-B1 CUT PILE FABRIC WITH A REDUCED TENDENCY TO SHADE, PROCESS FOR ITS MANUFACTURE AND YARNS THEREFOR Deutsches Wollforschungsinstitut an der Rheinisch-Westfälischen Technischen Hochschule Aachen e.V. (DE) 1988-03-23 EP disclosed
EP-0168835-A2 Cut pile fabric with a reduced tendency to shade, process for its manufacture and yarns therefor Deutsches Wollforschungsinstitut an der Rheinisch-Westfälischen Technischen Hochschule Aachen e.V. (DE) 1986-01-22 EP disclosed
US-3742035-A METHOD FOR PREPARATION OF URETHANATED HYDROXYALKANE SULFONATES Lion Kabushiki Kaisha (JP) 1973-06-26 US disclosed
US-3715464-A High voltage hold-down circuit RCA LICENSING CORPORATION, TWO INDEPENDENCE WAY, PRINCETON, NJ 08540, A CORP. OF DE 1973-02-06 US disclosed